Stay updated on Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.

Latest updates to the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page
- CheckyesterdayChange DetectedAn addition appears in the study identifiers: '2019 ( U.S. NIH Grant/Contract )', indicating NIH funding for the U.S. portion of the trial.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new post hoc analysis publication is added to the Publications section, and the previously listed publication entry is removed/updated to reflect its publication status.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page now lists Revision: v3.6.4, replacing the previous v3.6.3. This appears to be a minor revision tag update with no substantive changes to the study content in the provided data.SummaryDifference0.0%

- Check51 days agoChange DetectedA new PubMed publication citation by Weidinger et al. was added to the Publications section for the study. The page version was updated from v3.6.2 to v3.6.3.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page's revision tag advanced from v3.6.0 to v3.6.2, signaling a minor update to the page's documentation. The change does not modify trial content or functionality.SummaryDifference0.0%

- Check72 days agoChange DetectedRecruitment status updated to 'No longer looking for participants' and new help sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The page introduces an Intervention/Treatment section header while removing the previous Intervention / Treatment header, and the site revision version updated to v3.6.0.SummaryDifference0.2%

Stay in the know with updates to Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.